Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > XLO Xilio Therapeutics > Detailed Quotes

XLO Xilio Therapeutics

Watchlist
2.300
-0.020-0.86%
Close  12/09 16:00 ET
2.3000.0000.00%
Post Mkt Price 12/09 16:40 ET
High
2.540
Open
2.430
Turnover
12.16K
Low
2.200
Pre Close
2.320
Volume
5.20K
Market Cap
63.18M
P/E(TTM)
Loss
52wk High
16.928
Shares
27.47M
P/E(Static)
Loss
52wk Low
2.010
Float Cap
24.54M
Bid/Ask %
0.00%
Historical High
27.950
Shs Float
10.67M
Volume Ratio
0.25
Historical Low
2.010
Dividend TTM
--
Div Yield TTM
--
P/B
0.50
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.05%
Amplitude
14.66%
Avg Price
2.337
Lot Size
1
Float Cap
24.54M
Bid/Ask %
0.00%
Historical High
27.950
Shs Float
10.67M
Volume Ratio
0.25
Historical Low
2.010
Dividend TTM
--
P/B
0.50
Dividend LFY
--
Turnover Ratio
0.05%
Amplitude
14.66%
Avg Price
2.337
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.
CEO: Dr. Rene Russo, Pharm.D.
Market: NASDAQ
Listing Date: 10/22/2021
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist